BioTech IQ
En podkast av Ammon Rivera
67 Episoder
-
#47 Can Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhD
Publisert: 29.4.2022 -
#46 How Is Translational Genomics Reducing Background Noise In Multi-Disease Detection? With Aiguo "Adam" Zhang
Publisert: 22.4.2022 -
#45 Does company culture really affect drug development?
Publisert: 15.4.2022 -
#44 Addressing One Of The World’s Biggest Drivers Of Disease: Inflammation With Jim Woody, M.D., Ph.D. - CEO 180 Life Sciences
Publisert: 1.4.2022 -
#43 How to leverage past experience in developing treatments for rare disease. James Mackay, PhD - CEO, Aristea Therapeutics
Publisert: 25.3.2022 -
#42 Regenerative Medicine? How two companies are attacking nerve damage.
Publisert: 12.3.2022 -
#41 Is axonal transport the key to solving neurodegenerative diseases? Maria Maccechini, PhD - CEO, Annovis Bio
Publisert: 4.3.2022 -
#40 Treatments that can reach beyond on the function of drugs? James Joyce, CEO - Sigyn Therapeutics
Publisert: 25.2.2022 -
#39 How can digital health change the success of patient care? Waqaas Al-Siddiq, DBA, CEO - Biotricity
Publisert: 18.2.2022 -
Bonus Episode! Digital Health Panel with Biotricity and DarioHealth
Publisert: 17.2.2022 -
#37 How many lives would be changed with effective prevention of thromboembolic events? John Glasspool, CEO of Anthos Therapeutics
Publisert: 11.2.2022 -
#36 Can Shoreline Biosciences change the future of cell therapy through pluripotent stem cells?
Publisert: 4.2.2022 -
#35 Can Biomea Change the World with Irreversible Drugs and Covalent Bonds? Thomas Butler, CEO - Biomea Fusion
Publisert: 4.1.2022 -
#33 Reducing friction at Clinical Trial Start-Up - Sam Searcy, CEO of CliniStart
Publisert: 18.12.2021 -
#32 People, the most valuable asset a business has. Brenda Sousa - Chief HR Officer
Publisert: 13.12.2021 -
#31 Managing CRO relationships and unique business models - Stewart Hallet - COO SFJ Pharmaceuticals
Publisert: 24.11.2021 -
#30 Brazen Bio Part II - Live and In Person!
Publisert: 4.11.2021 -
#29 Why do we resist? Applying clinical psychology to clinical trials. Kathleen Starr, PhD - EVP Behavioral Insights, Syneos Health
Publisert: 29.10.2021 -
#28 Vaccine Durability, Diversified Pipeline, Winning Strategy - Seth Lederman, MD - CEO Tonix Pharmaceuticals
Publisert: 1.10.2021 -
#27 How do you effectively manage the CMC process? With Doug Looker, PhD
Publisert: 21.9.2021
Increase your IQ and understanding of the Biotech industry by listening to interviews with key business leaders who have built successful companies and departments. We discuss everything from the science, clinical operations, clinical development, safety/PV and more! We address how each function plays an important role in the drug approval process. We also discuss the people that make up these departments. Get ready to hear about cutting edge development and the people who make it happen!
